During the past decade, SPDC Villa Scassi conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "SPDC Villa Scassi" are "Urinary Bladder Neoplasms" (2 trials) and "Urothelial Cancer" (1 trials). Many other conditions were trialed in "SPDC Villa Scassi" in a lesser frequency.

Most popular intervention types in "SPDC Villa Scassi" are "Drug" (3 trials), "Biological" (2 trials), "Device" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cetrelimab" (2 trials), "TAR-200" (2 trials), "Cisplatin" (1 trials), "Conventional radiation therapy" (1 trials) and "Docetaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "SPDC Villa Scassi" are 3 trials for "All" genders.

Currently, there are NaN active trials in "SPDC Villa Scassi". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in SPDC Villa Scassi, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in SPDC Villa Scassi, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".